Wilson Therapeutics

Wilson Therapeutics is a biopharmaceutical company developing new therapies for patients with rare diseases such as Wilson's disease. Wilson Therapeutics' lead product, Decuprate, was initially developed as a new therapy for Wilson's disease and is currently being evaluated in a Phase II clinical study in patients with Wilson's disease.